{
    "pmid": "41472675",
    "title": "Rational Design of Multiclade Coronavirus Spike Immunodominant Domain Nanoparticles to Elicit Broad Antibody Responses.",
    "abstract": "Four seasonal endemic human coronaviruses (HCoVs), HCoV-HKU1, HCoV-OC43, HCoV-229E, and HCoV-NL63, are culprits of mild upper respiratory and periodic severe diseases in vulnerable populations. Despite their prevalence, understanding HCoVs' antigenic and immune signatures remains elusive. SARS-CoV-2 has evolved as the fifth HCoV, requiring seasonal vaccination, and currently, no other HCoV vaccines are available. SARS-CoV-2 co-infection with HCoVs increases disease severity; thus, combined vaccination may provide increased protection against seasonal HCoVs overall. Here, we explored spike (S) receptor binding domain (RBD) vs. N-terminal domain (NTD) B-cell immunodominance in HCoV-positive convalescent donors and immunogenicity in mice. We found that while antibody and B-cell isotypes were relatively dominant to S NTD, mice immunized with S RBD elicited significantly higher binding and neutralizing antibody (nAb) responses. With that knowledge, we used computational methods to infer that HCoV S sequences evolve into two main clades and designed chimeric immunodominant domains (IDDs) from both clades for each HCoV. IDDs were scaffolded onto two-component nanoparticles (NPs) displaying each IDD separately (monovalent IDD NP); three ÃŸ-HCoV IDDs (Mosaic-3 IDD NP); or five HCoVs IDDs (Mosaic-5 IDD NP). Mice immunized with mosaic IDD NPs, but not soluble IDD antigens nor monovalent IDD NPs, elicited potent, broadly cross-reactive binding and neutralizing antibody (Ab) responses against SARS-CoV-2 variants, other HCoVs, and Sarbecoviruses. System serology revealed that all four IDD immunogens elicited distinct Ab subclasses and Fc-effector functions, with mosaic-5 IDD NPs eliciting the most de novo Ab subclasses, distributions, and broader Fc-mediated immune mechanisms. Dissection of vaccine-immune sera revealed polyclonal Ab responses against multiple non-overlapping cross-reactive S epitopes. Due to elicitation of broad Ab responses with combinatory functionality, IDD NPs open new horizons for developing first-in-class supraseasonal HCoV vaccine candidates, with potential to decrease frequent SARS-CoV-2 sequence updates and protect against other HCoVs. Moreover, elicitation of Ab breadth that spans pandemic-threat Sarbecoviruses gives mosaic IDD NPs promise towards pandemic preparedness.",
    "disease": "covid-19",
    "clean_text": "rational design of multiclade coronavirus spike immunodominant domain nanoparticles to elicit broad antibody responses four seasonal endemic human coronaviruses hcovs hcov hku hcov oc hcov e and hcov nl are culprits of mild upper respiratory and periodic severe diseases in vulnerable populations despite their prevalence understanding hcovs antigenic and immune signatures remains elusive sars cov has evolved as the fifth hcov requiring seasonal vaccination and currently no other hcov vaccines are available sars cov co infection with hcovs increases disease severity thus combined vaccination may provide increased protection against seasonal hcovs overall here we explored spike s receptor binding domain rbd vs n terminal domain ntd b cell immunodominance in hcov positive convalescent donors and immunogenicity in mice we found that while antibody and b cell isotypes were relatively dominant to s ntd mice immunized with s rbd elicited significantly higher binding and neutralizing antibody nab responses with that knowledge we used computational methods to infer that hcov s sequences evolve into two main clades and designed chimeric immunodominant domains idds from both clades for each hcov idds were scaffolded onto two component nanoparticles nps displaying each idd separately monovalent idd np three hcov idds mosaic idd np or five hcovs idds mosaic idd np mice immunized with mosaic idd nps but not soluble idd antigens nor monovalent idd nps elicited potent broadly cross reactive binding and neutralizing antibody ab responses against sars cov variants other hcovs and sarbecoviruses system serology revealed that all four idd immunogens elicited distinct ab subclasses and fc effector functions with mosaic idd nps eliciting the most de novo ab subclasses distributions and broader fc mediated immune mechanisms dissection of vaccine immune sera revealed polyclonal ab responses against multiple non overlapping cross reactive s epitopes due to elicitation of broad ab responses with combinatory functionality idd nps open new horizons for developing first in class supraseasonal hcov vaccine candidates with potential to decrease frequent sars cov sequence updates and protect against other hcovs moreover elicitation of ab breadth that spans pandemic threat sarbecoviruses gives mosaic idd nps promise towards pandemic preparedness"
}